首页> 美国卫生研究院文献>Human Vaccines Immunotherapeutics >Predicting related factors of immunological response to hepatitis B vaccine in hemodialysis patients based on integration of decision tree classification and logistic regression
【2h】

Predicting related factors of immunological response to hepatitis B vaccine in hemodialysis patients based on integration of decision tree classification and logistic regression

机译:基于决策树分类和 logistic 回归的整合预测血液透析患者对乙型肝炎疫苗免疫反应的相关因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The non/hypo-response rate of the hepatitis B vaccine among hemodialysis (HD) patients is still high, it is of great significance to explore the influencing factors and their relationships. To study the related factors and their relationships using logistic regression model and Chi-squared Automatic Interaction Detection (CHAID) decision tree model. A randomized controlled trial was conducted between February 2014 and May 2015 in China. HD patients being serologically negative for HBsAg and anti-HBs were randomly assigned to receive three intramuscular injections of the standard dose (20 µg) or high dose (60 µg) of recombinant hepatitis B vaccine at months 0, 1, and 6. Those with anti-HBs concentrations 4 times per 2 weeks) (OR = 1.918, 95%CI: 1.015–3.626) had a significant risk of non/hypo-response. While the CHAID analysis showed that gender, dose, and dialysis frequency were influencing factors of non/hypo-response, and gender is most important. The interaction between gender and dialysis frequency had the greatest effect on immunization, and followed by the interaction between dialysis frequency and vaccine dose. Taken together, gender, dose and dialysis frequency were influencing factors of hepatitis B vaccine in HD patients.
机译:血液透析 (HD) 患者乙型肝炎疫苗的无反应率/低反应率仍然很高,探讨影响因素及其关系具有重要意义。使用 logistic 回归模型和卡方自动交互检测 (CHAID) 决策树模型研究相关因素及其关系。2014 年 2 月至 2015 年 5 月在中国进行了一项随机对照试验。血清学 HBsAg 和抗 HBs 阴性的 HD 患者被随机分配在第 0 、 1 和 6 个月接受 3 次标准剂量 (20 μg) 或高剂量 (60 μg) 重组乙型肝炎疫苗的肌肉注射。第 7 个月时抗 HBs 浓度为 每 2 周 4 次) (OR = 1.918, 95%CI: 1.015–3.626) 具有无/低反应的显着风险。而 CHAID 分析显示,性别、剂量和透析频率是无反应/低反应的影响因素,其中性别最为重要。性别与透析频率之间的交互作用对免疫接种的影响最大,其次是透析频率与疫苗剂量之间的交互作用。综上所述,性别、剂量和透析频率是 HD 患者接种乙型肝炎疫苗的影响因素。

著录项

代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号